A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity

✍ Scribed by Awwad, J; Usta, IM; Ghazeeri, G; Yacoub, N; Succar, J; Hayek, S; Saasouh, W; Nassar, AH

• Book ID: 127259609
• Publisher: John Wiley and Sons
• Year: 2014
• Tongue: English
• Weight: 189 KB
• Volume: 122
• Category: Article
• ISSN: 1470-0328
• DOI: 10.1111/1471-0528.13031